VBLTVKI (Von Karman Institute for Fluid Dynamics) Boundary Layers in Turbomachines (technical periodical)
References in periodicals archive ?
VBL Therapeutics (VBLT), up 11% after presenting data indicating that the viral anti-cancer investigational therapy VB-111 has potential to stimulate the immune system to induce a strong and durable response against ovarian tumors...
He presently serves as a director at Vascular Biogenics Ltd (NASDAQ: VBLT).
Release date- 05082019 - VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Tuesday, August 13 at 8:30am Eastern Time to report second quarter and six-months ended June 30, 2019financial results and to provide a corporate update.